Avidian Wealth Solutions LLC Sells 189 Shares of The Procter & Gamble Company (NYSE:PG)

Avidian Wealth Solutions LLC cut its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 1.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,303 shares of the company’s stock after selling 189 shares during the period. Avidian Wealth Solutions LLC’s holdings in Procter & Gamble were worth $2,645,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of PG. Advantage Trust Co bought a new stake in Procter & Gamble during the 4th quarter worth $28,000. Naples Money Management LLC bought a new stake in Procter & Gamble during the 4th quarter worth approximately $29,000. Wyrmwood Management LLC bought a new stake in Procter & Gamble during the 4th quarter worth approximately $29,000. Transcendent Capital Group LLC bought a new stake in Procter & Gamble during the 4th quarter worth approximately $31,000. Finally, MeadowBrook Investment Advisors LLC bought a new stake in Procter & Gamble during the 4th quarter worth approximately $33,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Shares of NYSE:PG traded up $1.07 during trading on Wednesday, hitting $166.73. 5,036,807 shares of the company were exchanged, compared to its average volume of 6,528,171. The company has a market cap of $393.51 billion, a PE ratio of 27.13, a P/E/G ratio of 3.18 and a beta of 0.41. The stock has a 50 day moving average of $165.97 and a 200 day moving average of $159.85. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $169.41. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The company had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. During the same quarter last year, the business posted $1.37 earnings per share. The firm’s revenue was up .6% compared to the same quarter last year. As a group, equities research analysts predict that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a dividend of $1.0065 per share. The ex-dividend date is Friday, July 19th. This represents a $4.03 dividend on an annualized basis and a yield of 2.41%. Procter & Gamble’s payout ratio is 65.85%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on PG. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Procter & Gamble from $172.00 to $171.00 and set a “buy” rating on the stock in a research note on Monday, April 22nd. StockNews.com raised shares of Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Tuesday, June 25th. Barclays increased their target price on shares of Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 23rd. Argus increased their target price on shares of Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. Finally, BNP Paribas initiated coverage on shares of Procter & Gamble in a research note on Monday, June 24th. They set an “outperform” rating and a $187.00 target price on the stock. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $170.72.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Sundar G. Raman sold 31,924 shares of the firm’s stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $166.95, for a total transaction of $5,329,711.80. Following the sale, the chief executive officer now owns 19,042 shares in the company, valued at $3,179,061.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, insider Balaji Purushothaman sold 28,369 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the transaction, the insider now directly owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Sundar G. Raman sold 31,924 shares of the firm’s stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $166.95, for a total value of $5,329,711.80. Following the transaction, the chief executive officer now directly owns 19,042 shares in the company, valued at $3,179,061.90. The disclosure for this sale can be found here. Insiders have sold 154,544 shares of company stock worth $25,413,051 over the last 90 days. Corporate insiders own 0.17% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.